In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Otrasel Drug Master File in Korea (Otrasel KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Otrasel. The MFDS reviews the Otrasel KDMF as part of the drug registration process and uses the information provided in the Otrasel KDMF to evaluate the safety and efficacy of the drug.
After submitting a Otrasel KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Otrasel API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Otrasel suppliers with KDMF on PharmaCompass.